Treatment outcome of Philadelphia chromosome negative myeloproliferative neoplasms: experience of a single developing country ’s hematology-oncology centre
Conclusion: Clinical and laboratory improvements were presented in MPNs patients. Regular follow up of patients are essential to ensure prescribed treatment in addition to the continual and long-lasting response to therapy and to prevent thrombosis.Keywords: Cytoreductive treatment, MPNs, JAK2 mutation.
Source: African Health Sciences - Category: African Health Source Type: research
More News: African Health | Cancer & Oncology | Hematology | Iraq Health | Laboratory Medicine | Middle East Health | Myeloproliferative Disorders | Thrombosis